Your browser doesn't support javascript.
loading
The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9ß1 and α4ß1.
Morris, Gavin E; Denniff, Matthew J; Karamanavi, Elisavet; Andrews, Sarah A; Kostogrys, Renata B; Bountziouka, Vasiliki; Ghaderi-Najafabadi, Maryam; Shamkhi, Noor; McConnell, George; Kaiser, Michael A; Carleton, Laura; Schofield, Christine; Kessler, Thorsten; Rainbow, Richard D; Samani, Nilesh J; Webb, Thomas R.
  • Morris GE; Department of Cardiovascular Sciences, University of Leicester and National Institute for Health Research Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
  • Denniff MJ; Department of Cardiovascular Sciences, University of Leicester and National Institute for Health Research Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
  • Karamanavi E; Department of Cardiovascular Sciences, University of Leicester and National Institute for Health Research Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
  • Andrews SA; Department of Cardiovascular Sciences, University of Leicester and National Institute for Health Research Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
  • Kostogrys RB; Department of Human Nutrition, Faculty of Food Technology, University of Agriculture in Krakow, Krakow, Poland.
  • Bountziouka V; Department of Cardiovascular Sciences, University of Leicester and National Institute for Health Research Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
  • Ghaderi-Najafabadi M; Department of Cardiovascular Sciences, University of Leicester and National Institute for Health Research Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
  • Shamkhi N; Department of Cardiovascular Sciences, University of Leicester and National Institute for Health Research Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
  • McConnell G; Department of Cardiovascular Sciences, University of Leicester and National Institute for Health Research Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
  • Kaiser MA; Department of Cardiovascular Sciences, University of Leicester and National Institute for Health Research Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
  • Carleton L; Horizon Discovery Ltd., Cambridge, UK.
  • Schofield C; Horizon Discovery Ltd., Cambridge, UK.
  • Kessler T; Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Munich, Germany.
  • Rainbow RD; German Centre of Cardiovascular Research (DZHK e. V.), Partner Site Munich Heart Alliance, Munich, Germany.
  • Samani NJ; Department of Cardiovascular and Metabolic Medicine & Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, UK.
  • Webb TR; Department of Cardiovascular Sciences, University of Leicester and National Institute for Health Research Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
Br J Pharmacol ; 179(21): 4958-4973, 2022 11.
Article en En | MEDLINE | ID: mdl-35802072
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Integrina alfa4beta1 / Células Madre Pluripotentes Inducidas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Integrina alfa4beta1 / Células Madre Pluripotentes Inducidas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article